Here, using natural hematoxylin (HT) as linker, metal‐organic frameworks (MOFs) from Cu(II), Fe(II), and Fe(III) ions was prepared. The SEM images and DLS analyses revealed HT‐based MOFs are <micrometer sizes with the highest surface area value of 49.2 m2/g for HT‐Fe(III) MOFs. Interestingly, HT‐based MOFs exhibit fluorescent properties at λem=330 nm with fluorescence intensities of 11485, 2120, and 6790 (a.u) for HT‐Cu(II), Fe(II), and Fe(III) MOFs, respectively. Moreover, HT‐based MOFs inhibited α‐glucosidase enyzme in a concentration‐dependent manner e.g., 33.1%, 69.8%, and 59.7% of Cenzyme=500 mg/mL was inhibited by HT‐Cu(II)‐MOF, HT‐Fe(II)‐MOF, and HT‐Fe(III)‐MOFs, respectively. The minimum bactericidal concentration (MBC) values of HT‐Cu(II) MOFs for Escherichia coli (gram ‐), Staphylococcus aureus (gram +), and Candida albicans are determined as 5, 5, and 10 mg/mL, respectively. Also, the antioxidant activities of 250 ppm HT‐based MOF based on total phenol content (TPC) tests revealed 279, 208, 124, and 152 mg.gallic acid equivalent/mL (mg GA equivalency/mL) for HT, HT‐Cu(II) MOF, HT‐Fe(II) MOF, and HT‐Fe(III), respectively affirming that antioxidant properties were retained. Moreover, HT‐Fe(II) and HT‐Fe(III) MOFs (62.5 µg/mL) against human null‐1 lung cell line revealed cell viabilities of 98.7±12.2% and 88.9±11.7%, respectively as concentration‐dependent biocompatibility of MOFs.